• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore.

作者信息

Lee Rui En, Qi Yap Charyl Jia, Tang Tjun Yip

机构信息

Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Department of Vascular Surgery, Singapore General Hospital, Singapore.

出版信息

Singapore Med J. 2022 Aug;63(8):488. doi: 10.4103/singaporemedj.SMJ-2022-142.

DOI:10.4103/singaporemedj.SMJ-2022-142
PMID:36259574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9584065/
Abstract
摘要

相似文献

1
Response to comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore.对以下评论的回复：新加坡一家亚洲三级血管中心针对慢性肢体威胁性缺血进行下肢血管腔内血管重建术后的两年临床结果
Singapore Med J. 2022 Aug;63(8):488. doi: 10.4103/singaporemedj.SMJ-2022-142.
2
Comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore.关于《新加坡一家亚洲三级血管中心下肢慢性威胁肢体缺血血管腔内再血管化治疗的两年临床结果》的评论
Singapore Med J. 2022 Aug;63(8):488. doi: 10.4103/singaporemedj.SMJ-2022-141.
3
Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore.新加坡一家三级亚洲血管中心对慢性肢体威胁性缺血进行下肢血管腔内再血管化治疗的两年临床结果。
Singapore Med J. 2022 Feb;63(2):79-85. doi: 10.11622/smedj.2020104. Epub 2020 Jul 16.
4
Real Life Outcomes of Infrapopliteal Endovascular and Surgical Bypass Intervention for Chronic Limb Threatening Ischaemia in GLASS Stages II and III.GLASS 分期 II 和 III 级慢性肢体缺血性威胁患者的腘动脉以下腔内血管和旁路手术干预的实际临床转归。
Eur J Vasc Endovasc Surg. 2022 Jul;64(1):41-48. doi: 10.1016/j.ejvs.2022.04.036. Epub 2022 May 7.
5
Outcomes and Costs of Open and Endovascular Revascularisation for Chronic Limb Ischaemia in an Australian Cohort.澳大利亚队列中慢性肢体缺血的开放和血管内再血管化治疗的结局和成本。
Heart Lung Circ. 2021 Oct;30(10):1552-1561. doi: 10.1016/j.hlc.2021.04.016. Epub 2021 May 25.
6
Health Related Quality of Life Over Time After Revascularisation in Patients With Chronic Limb Threatening Ischaemia.慢性肢体威胁性缺血患者血运重建后生存质量随时间的变化
Eur J Vasc Endovasc Surg. 2021 Nov;62(5):777-785. doi: 10.1016/j.ejvs.2021.06.037. Epub 2021 Sep 13.
7
Comparison of Long Term Outcomes After Endovascular Treatment Versus Bypass Surgery in Chronic Limb Threatening Ischaemia Patients with Long Femoropopliteal Lesions.比较长段股腘动脉病变的慢性肢体缺血威胁患者腔内治疗与旁路移植手术的长期疗效。
Eur J Vasc Endovasc Surg. 2021 Feb;61(2):258-269. doi: 10.1016/j.ejvs.2020.11.009. Epub 2020 Dec 15.
8
Editor's Choice - Impact of Comorbidity, Medication, and Gender on Amputation Rate Following Revascularisation for Chronic Limb Threatening Ischaemia.编辑精选 - 合并症、药物治疗和性别对慢性肢体威胁性缺血血管重建术后截肢率的影响。
Eur J Vasc Endovasc Surg. 2018 Nov;56(5):681-688. doi: 10.1016/j.ejvs.2018.06.003. Epub 2018 Aug 6.
9
Influence of time interval between endovascular intervention and free flap transfer on flap outcomes in critical limb-threatening ischemia: A retrospective analysis of 64 consecutive cases.血管内介入治疗与游离皮瓣移植时间间隔对严重肢体缺血患者皮瓣转归的影响：64 例连续病例的回顾性分析。
J Plast Reconstr Aesthet Surg. 2021 Jul;74(7):1544-1552. doi: 10.1016/j.bjps.2020.12.051. Epub 2020 Dec 26.
10

本文引用的文献

1
Comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore.关于《新加坡一家亚洲三级血管中心下肢慢性威胁肢体缺血血管腔内再血管化治疗的两年临床结果》的评论
Singapore Med J. 2022 Aug;63(8):488. doi: 10.4103/singaporemedj.SMJ-2022-141.
2
Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial.慢性阻塞性肺疾病与外周动脉疾病患者的发病率和死亡率的关系：来自 EUCLID 试验的见解。
Int J Chron Obstruct Pulmon Dis. 2021 Mar 29;16:841-851. doi: 10.2147/COPD.S292978. eCollection 2021.
3
Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore.新加坡一家三级亚洲血管中心对慢性肢体威胁性缺血进行下肢血管腔内再血管化治疗的两年临床结果。
Singapore Med J. 2022 Feb;63(2):79-85. doi: 10.11622/smedj.2020104. Epub 2020 Jul 16.
4
Peripheral Artery Disease in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者的外周动脉疾病
Am J Respir Crit Care Med. 2017 Jan 15;195(2):148-150. doi: 10.1164/rccm.201608-1712ED.
5
Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients.外周动脉疾病：慢性阻塞性肺疾病患者运动不耐受的一个被低估的病因。
Eur J Cardiovasc Prev Rehabil. 2008 Jun;15(3):270-7. doi: 10.1097/HJR.0b013e3282f009a9.
6
Estimated functional capacity predicts mortality in older adults.估计的功能能力可预测老年人的死亡率。
J Am Geriatr Soc. 2007 Dec;55(12):1940-7. doi: 10.1111/j.1532-5415.2007.01455.x. Epub 2007 Nov 2.